Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
8-K - GAXOS.AI INC. (0001895618) (Filer)
424B5 - GAXOS.AI INC. (0001895618) (Filer)
10-K - GAXOS.AI INC. (0001895618) (Filer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
Acquisition Provides Exposure to Emerging US Defense Technologies with Multi-Sector National Security Applications Roseland, NJ, March 03, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that it acquired a 19.99% stake in America First Defense ("AFD"), a US-based defense technology company developing next-generation drone and robotics platforms. America First Defense is an American-owned defense technology company developing next-generation security platforms across both air and ground domains. The company is focused on two high-priority categories: a detachab
Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio
Roseland, NJ, March 24, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that its portfolio company, America First Defense ("AFD"), began deployment the Anduril Lattice Platform, expanding Counter-Swarm UAV and Anti-Drone Defense Systems. The deployment marks an important operational milestone for AFD as it advances its next-generation autonomous defense infrastructure designed to identify, track, assess, and respond to increasingly sophisticated unmanned aerial threats. By integrating Anduril's Lattice platform into its broader defense architecture, AFD is stre
This achievement underscores America First Defense's accelerating traction in the defense industry and highlights its commitment to delivering cutting-edge counter-drone solutions. Roseland, NJ, March 18, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that its portfolio company, America First Defense ("AFD"), has secured acceptance into Anduril's Lattice Program, a development that further strengthens AFD's position in the rapidly growing counter-drone defense market. The acceptance marks an important milestone for AFD as it continues to expand its presence
U.S. Army Commanding General (Ret.) to Help Guide Next-Generation Counter-Drone Innovation, AI and Robotics Roseland, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that Malcolm B. Frost, a retired Major General in the United States Army, has joined America First Defense ("AFD") Drone and Robotics Advisory Council. Major General Frost brings decades of operational and strategic experience in modern warfare, military communications, and advanced defense technologies. Throughout his distinguished career, he held multiple senior leadership roles wi
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D. is a Board-Ce
SC 13G - GAXOS.AI INC. (0001895618) (Subject)